Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Neoplasms

Explore clinical trials studying Central Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

1,870 public trials 483 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Neoplasms trial results

Recruiting

Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

NCT06888817

Conditions
Brain Diseases, Brain Metastasases, Brain Neoplasms, +20 more
Locations
  • Netherlands Cancer Institute - Antoni van Leeuwenhoek Amsterdam, Netherlands
  • Amsterdam University Medical Centers, location VUmc and AMC Amsterdam, Netherlands
  • Leiden University Medical Center Leiden, Netherlands
  • Maastricht University Medical Center+ Maastricht, Netherlands
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

NCT05538130

Conditions
Advanced or Metastatic Solid Tumors, Brain Diseases, Brain Neoplasms, +41 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham - Phase I Clinical Trials Unit Birmingham, Alabama, United States
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
View all 83 locations
View Trial Details
Recruiting

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

NCT02422641

Conditions
Breast Diseases, Breast Neoplasms, Central Nervous System Neoplasms, +9 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Siteman Cancer Center- Washington University School of Medicine in St. Louis St Louis, Missouri, United States
  • Comprehensive Cancer Center at Wake Forest University (CCCWFU) Winston-Salem, North Carolina, United States
View Trial Details
Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

NCT02523014

Conditions
Central Nervous System Neoplasms, Intracranial Meningioma, Meningeal Neoplasms, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 780 locations
View Trial Details
Recruiting

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

NCT04804644

Conditions
Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +17 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Bellflower Bellflower, California, United States
  • Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States
View all 231 locations
View Trial Details

Related conditions